These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Drug-eluting stent insertion in the treatment of in-stent renal artery restenosis in three renal transplant recipients. Douis H; Shabir S; Lipkin G; Riley P J Vasc Interv Radiol; 2008 Dec; 19(12):1757-60. PubMed ID: 18952465 [TBL] [Abstract][Full Text] [Related]
3. Restenosis after stenting of atherosclerotic renal artery stenosis: is there a rationale for the use of drug-eluting stents? Zeller T; Rastan A; Rothenpieler U; Müller C Catheter Cardiovasc Interv; 2006 Jul; 68(1):125-30. PubMed ID: 16755597 [TBL] [Abstract][Full Text] [Related]
8. Management of distal/bifurcation left main restenosis after drug eluting stents implantation: single center experience. Rigatelli G; Cardaioli P; Dell'Avvocata F; Giordan M; Vassilev D; Fraccaro C; Roncon L; Faggian G Cardiovasc Revasc Med; 2014 Mar; 15(2):76-9. PubMed ID: 24560299 [TBL] [Abstract][Full Text] [Related]
9. Sirolimus-eluting stent placement for refractory renal artery in-stent restenosis: sustained patency and clinical benefit at 24 months. Lookstein RA; Talenfeld AD; Raju R; Vorchheimer DA; Olin JW; Marin ML Vasc Med; 2009 Nov; 14(4):361-4. PubMed ID: 19808721 [TBL] [Abstract][Full Text] [Related]
10. The potential role of DES in peripheral in-stent restenosis. Zeller T; Macharzina R; Tepe G J Cardiovasc Surg (Torino); 2010 Aug; 51(4):561-5. PubMed ID: 20671640 [TBL] [Abstract][Full Text] [Related]